Symmetry CABG Connector Leads St. Jude Cardiac Surgery Unit Growth
This article was originally published in The Gray Sheet
Executive Summary
The rapid market adoption of the Symmetry sutureless aortic connector device for coronary bypass surgery (CABG) has offset declining sales of St. Jude's mechanical heart valve line, the company reported during its Jan. 30 quarterly conference call
You may also be interested in...
J&J CorLink Anastomotic Clips To Compete With St. Jude's Symmetry
Johnson & Johnson's Ethicon unit expects to launch its CorLink automated aortic anastomotic coupling system in Europe by year-end. A U.S. launch is targeted for mid-2002 pending 510(k) clearance.
Less Invasive CABG Facilitated By St. Jude Connector Devices, Firm Believes
The long-term reliability of St. Jude Medical's sutureless anastomotic Connector devices could shift the coronary therapy market away from stents and toward bypass surgery (CABG), the company suggested during a May 1 investor conference.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.